NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
256-270 of 394

Research Identifies a Potential Link Between Sleep Apnea and Memory Loss
NeuroFrontiersResearch Identifies a Potential Link Between Sleep Apnea and Memory Loss

Breastfeeding with MS: Monoclonal Antibodies May Not Impact Child Development
NeuroFrontiersBreastfeeding with MS: Monoclonal Antibodies May Not Impact Child Development

A Potential Treatment for Parkinson's Disease Showing Safety and Tolerability
NeuroFrontiersA Potential Treatment for Parkinson's Disease Showing Safety and Tolerability

Exploring the Clinical Treatments of Schizophrenia
NeuroFrontiersExploring the Clinical Treatments of Schizophrenia

The Role of Occupational Therapy in Schizophrenia Management
NeuroFrontiersThe Role of Occupational Therapy in Schizophrenia Management

Investigating the Prevalence of Comorbidities in MS Clinical Trials
NeuroFrontiersInvestigating the Prevalence of Comorbidities in MS Clinical Trials
- advertisement

Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
NeuroFrontiersDisparities in DMT Access: Women with MS Are Less Likely to Receive Treatment

Assessing Disability in MS Patients with the SNRS and CombiWISE Tools
NeuroFrontiersAssessing Disability in MS Patients with the SNRS and CombiWISE Tools

The Alarming Shortage of ADHD Medication and Its Implications on Patients
NeuroFrontiersThe Alarming Shortage of ADHD Medication and Its Implications on Patients

Practices for Preventing Polypharmacy in Multiple Sclerosis
NeuroFrontiersPractices for Preventing Polypharmacy in Multiple Sclerosis

Understanding the Cellular Basis for Altered Cognition in Schizophrenia
NeuroFrontiersUnderstanding the Cellular Basis for Altered Cognition in Schizophrenia

From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
NeuroFrontiersFrom Assessment to Management: Tackling Catatonia in Schizophrenic Patients
- advertisement

How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
NeuroFrontiersHow Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors

Exploring the Latest in MS Cognitive Rehabilitation Strategies
NeuroFrontiersExploring the Latest in MS Cognitive Rehabilitation Strategies

Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
NeuroFrontiersAdvancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum









































